Hepcidin-25 in Diabetic Chronic Kidney Disease Is Predictive for Mortality and Progression to End Stage Renal Disease

• Martin Wagner ,

  * E-mail: wagner_m@ukw.de

  Affiliations Division of Nephrology, Department of Medicine I, University Hospital Würzburg, Würzburg, Germany, Institute of Clinical Epidemiology and Biometry, University of Würzburg, Würzburg, Germany, Comprehensive Heart Failure Center, University of Würzburg, Würzburg, Germany

  ⨯
• Damien R. Ashby,

  Affiliation Kidney and Transplant Institute, Imperial College, London, United Kingdom

  ⨯
• Caroline Kurtz,

  Affiliation Division of Nephrology, Department of Medicine I, University Hospital Würzburg, Würzburg, Germany

  ⨯
• Ahsan Alam,

  Affiliation Division of Nephrology, McGill University, Montreal, Canada

  ⨯
• Mark Busbridge,

  Affiliation Department of Clinical Chemistry, Imperial College, London, United Kingdom

  ⨯
• Ulrike Raff,

  Affiliation Division of Nephrology and Hypertension, Department of Internal Medicine 4, University of Erlangen-Nürnberg, Erlangen, Germany

  ⨯
• Josef Zimmermann,

  Affiliation Division of Nephrology, Department of Medicine I, University Hospital Würzburg, Würzburg, Germany

  ⨯
• Peter U. Heuschmann,

  Affiliations Institute of Clinical Epidemiology and Biometry, University of Würzburg, Würzburg, Germany, Comprehensive Heart Failure Center, University of Würzburg, Würzburg, Germany, Clinical Trial Unit, University Hospital Würzburg, Würzburg, Germany

  ⨯
• Christoph Wanner,

  Affiliation Division of Nephrology, Department of Medicine I, University Hospital Würzburg, Würzburg, Germany

  ⨯
• Lothar Schramm

  Affiliation Division of Nephrology, Department of Medicine I, University Hospital Würzburg, Würzburg, Germany

  ⨯